By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
American College of Chest Physicians and Canadian Thoracic Society Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions
Overview
This guideline was created by the American College of Chest Physicians and Canadian Thoracic Society to help clinicians and patients gauge the appropriate use of cannabinoid-based medicines in the management of chronic pain and co-concurring conditions.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: April 1, 2024
Contact: practice@apta.org
Content Type: CPG
Cancer, Chronic Pain, Depression, Fibromyalgia, Headaches, Multiple Sclerosis, Osteoarthritis, Sleep Disorders
Adult (25-44), Middle Aged (45-64), Aged (65+), 80 and over (80+)
Bell AD, MacCallum C, Margolese S, et al.
You Might Also Like...
Clinical Summary
Knee OsteoarthritisNov 13, 2024
OA may be accompanied by pain, immobility, muscle weakness, and a decrease in function and activities of daily living.
CPG
EULAR Recommendations for the Non-Pharmacological Core Management of Hip and Knee Osteoarthritis: 2023 UpdateMay 15, 2024
These updated multidisciplinary recommendations focus on the nonpharmacological management of hip and knee osteoarthritis (OA).
CPG
American Academy of Orthopaedic Surgeons: Management of Osteoarthritis of the Hip Evidence-Based Clinical Practice GuidelineDec 1, 2023
The updated guideline consists of a systematic review of available literature regarding the management of hip osteoarthritis in adults and provides recommendations